130 related articles for article (PubMed ID: 12894597)
1. Biodistribution and scintigraphic studies of 153Sm-labeled anti-CEA monoclonal antibody for radioimmunoscintigraphy and radioimmunotherapy.
Fani M; Xanthopoulos S; Archimandritis SC; Stratis N; Bouziotis P; Loudos G; Varvarigou AD
Anticancer Res; 2003; 23(3A):2195-9. PubMed ID: 12894597
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study.
Li GP; Zhang H; Zhu CM
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):1-5. PubMed ID: 12527502
[TBL] [Abstract][Full Text] [Related]
3. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
[TBL] [Abstract][Full Text] [Related]
4. Labeling of monoclonal antibodies with samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy.
Boniface GR; Izard ME; Walker KZ; McKay DR; Sorby PJ; Turner JH; Morris JG
J Nucl Med; 1989 May; 30(5):683-91. PubMed ID: 2785586
[TBL] [Abstract][Full Text] [Related]
5. Labeling of monoclonal antibodies with 153Sm for potential use in radioimmunotherapy.
Fani M; Vranjes S; Archimandritis SC; Potamianos S; Xanthopoulos S; Bouziotis P; Varvarigou AD
Appl Radiat Isot; 2002 Nov; 57(5):665-74. PubMed ID: 12433040
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
7. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].
Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH
Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032
[TBL] [Abstract][Full Text] [Related]
8. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
[TBL] [Abstract][Full Text] [Related]
9. Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition.
Bouziotis P; Fani M; Archimandritis SC; Loundos G; Paravatou M; Bicknell R; Harris AL; Xanthopoulos S; Stratis N; Varvarigou AD
Anticancer Res; 2003; 23(3A):2167-71. PubMed ID: 12894592
[TBL] [Abstract][Full Text] [Related]
10. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
[TBL] [Abstract][Full Text] [Related]
11. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
[TBL] [Abstract][Full Text] [Related]
12. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer.
Almqvist Y; Steffen AC; Tolmachev V; Divgi CR; Sundin A
Nucl Med Biol; 2006 Nov; 33(8):991-8. PubMed ID: 17127172
[TBL] [Abstract][Full Text] [Related]
14. Anti-CEA monoclonal antibody: technetium-99m labeling and the validation process of a scintigraphic animal model with a non-cellular antigenic implant.
Sapienza MT; Marques FL; Okamoto MR; Hironaka FH; Buchpiguel CA
Cell Mol Biol (Noisy-le-grand); 2002 Jul; 48(5):511-6. PubMed ID: 12146705
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen.
Lu QJ; Bian GX; Chen YY; Zhang M; Guo SM; Wen LQ
Acta Pharmacol Sin; 2005 Oct; 26(10):1259-64. PubMed ID: 16174444
[TBL] [Abstract][Full Text] [Related]
16. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM
J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer.
Kraeber-Bodéré F; Mishra A; Thédrez P; Faivre-Chauvet A; Bardiès M; Imai S; Le Boterff J; Chatal JF
Eur J Nucl Med; 1996 May; 23(5):560-7. PubMed ID: 8698062
[TBL] [Abstract][Full Text] [Related]
18. Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors.
Delaloye AB; Delaloye B; Buchegger F; Vogel CA; Gillet M; Mach JP; Smith A; Schubiger PA
J Nucl Med; 1997 Jun; 38(6):847-53. PubMed ID: 9189128
[TBL] [Abstract][Full Text] [Related]
19. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
Gold DV; Goldenberg DM; Karacay H; Rossi EA; Chang CH; Cardillo TM; McBride WJ; Sharkey RM
Cancer Res; 2008 Jun; 68(12):4819-26. PubMed ID: 18559529
[TBL] [Abstract][Full Text] [Related]
20. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
Quadri SM; Vriesendorp HM
Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]